DEFERRARI, GIACOMO
 Distribuzione geografica
Continente #
EU - Europa 22.891
AS - Asia 2.218
NA - Nord America 944
SA - Sud America 159
AF - Africa 39
OC - Oceania 2
Totale 26.253
Nazione #
IT - Italia 22.521
SG - Singapore 1.011
US - Stati Uniti d'America 877
CN - Cina 606
VN - Vietnam 295
FR - Francia 188
BR - Brasile 108
BD - Bangladesh 103
HK - Hong Kong 87
CH - Svizzera 43
DE - Germania 42
MX - Messico 26
AR - Argentina 25
FI - Finlandia 21
JP - Giappone 21
GB - Regno Unito 20
CA - Canada 17
IN - India 15
IQ - Iraq 14
ID - Indonesia 11
ZA - Sudafrica 11
NL - Olanda 8
DZ - Algeria 7
IE - Irlanda 7
MA - Marocco 7
PH - Filippine 7
PL - Polonia 7
EC - Ecuador 6
RU - Federazione Russa 6
SC - Seychelles 6
VE - Venezuela 6
AZ - Azerbaigian 5
CO - Colombia 5
ES - Italia 5
JM - Giamaica 5
TW - Taiwan 5
UA - Ucraina 5
DO - Repubblica Dominicana 4
KR - Corea 4
PK - Pakistan 4
PY - Paraguay 4
SA - Arabia Saudita 4
TR - Turchia 4
DK - Danimarca 3
GT - Guatemala 3
JO - Giordania 3
NP - Nepal 3
PR - Porto Rico 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AU - Australia 2
BG - Bulgaria 2
BH - Bahrain 2
CL - Cile 2
EG - Egitto 2
IR - Iran 2
KE - Kenya 2
LT - Lituania 2
NI - Nicaragua 2
PA - Panama 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
BW - Botswana 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
GE - Georgia 1
HN - Honduras 1
HU - Ungheria 1
KG - Kirghizistan 1
KH - Cambogia 1
LV - Lettonia 1
ML - Mali 1
MN - Mongolia 1
MT - Malta 1
MY - Malesia 1
PE - Perù 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UY - Uruguay 1
YT - Mayotte 1
Totale 26.253
Città #
Genova 14.508
Genoa 4.449
Rapallo 2.153
Vado Ligure 1.298
Singapore 511
San Jose 324
Lauterbourg 182
Beijing 91
New York 90
Hong Kong 83
Ashburn 82
Hanoi 81
Ho Chi Minh City 78
Bordighera 51
Zurich 43
Santa Clara 40
Frankfurt am Main 35
Los Angeles 23
Helsinki 21
Mexico City 19
Tokyo 18
Tianjin 16
Orem 13
Da Nang 12
São Paulo 12
Haiphong 11
Dallas 10
Baghdad 9
Biên Hòa 7
City of London 7
Council Bluffs 7
Dublin 7
Rome 7
Amsterdam 6
Buffalo 6
Phoenix 6
San Francisco 6
Atlanta 5
Johannesburg 5
London 5
Milan 5
Toronto 5
Chicago 4
Guangzhou 4
Kansas City 4
Madrid 4
Naples 4
Baku 3
Bắc Ninh 3
Cao Lanh 3
Cardiff 3
Jacksonville 3
Montreal 3
Mumbai 3
Orangeburg 3
Pasadena 3
Quảng Ngãi 3
Shanghai 3
Thái Bình 3
Turin 3
Tây Ninh 3
Warsaw 3
Amman 2
Baton Rouge 2
Bogotá 2
Bologna 2
Brooklyn 2
Buenos Aires 2
Bình Phước 2
Can Tho 2
Chaguanas 2
Cincinnati 2
Conceição do Coité 2
Copenhagen 2
Cotia 2
Denver 2
Des Moines 2
Dhaka 2
Durban 2
Erbil 2
Fort Worth 2
Fortaleza 2
Goiânia 2
Guayaquil 2
Hải Dương 2
Istanbul 2
Jeddah 2
Kathmandu 2
Kingston 2
Las Vegas 2
Marseille 2
Nairobi 2
Nuremberg 2
Phủ Lý 2
Piscataway 2
Porto Alegre 2
Potomac 2
Purbalingga 2
Rabat 2
Riyadh 2
Totale 24.488
Nome #
L'AMMONIOGENESI RENALE NELL'UOMO 333
Accelerated senescence in the kidneys of patients with type 2 diabetic nephropathy 213
Androgen-mediated apoptosis of kidney tubule cells: role of c-Jun amino terminal kinase 206
Chronic kidney disease in hypertension under specialist care: the I-DEMAND study 200
ABNORMALITIES IN AMINO ACID METABOLISM IN CHRONIC RENAL FAILURE 198
Ambulatory arterial stiffness index and renal abnormalities in primary hypertension 197
Vitamin E-coated filter decreases levels of free 4-hydroxyl-2-nonenal during haemodialysis sessions 187
Increased renal resistive index in patients with essential hypertension: a marker of target organ damage. 184
C-reactive protein and target organ damage in untreated patients with primary hypertension. 180
5,10-Methylenetetrahydrofolate reductase polymorphism and early organ damage in primary hypertension. 178
Interorgan exchange of aminothiols in humans 175
Inter-organ leptin exchange in humans 174
Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients 174
Oxidative stress mediates apoptotic changes induced by hyperglycemia in human tubular kidney cells 172
Independent association of ECG abnormalities with microalbuminuria and renal damage in hypertensive patients without overt cardiovascular disease: data from Italy-Developing Education and awareness on MicroAlbuminuria in patients with hypertensive Disease study. 171
Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS 171
Abnormal amino acid metabolism after amino acid ingestion in chronic renal failure 169
Correlation between pentosidine and endothelin-1 in subjects undergoing chronic hemodialysis. 168
Blood pressure variability and multiple organ damage in primary hypertension 167
Mild hyperuricemia and subclinical renal damage in untreated primary hypertension 163
Effects of a protein meal on blood amino acid profile in patients with chronic renal failure. 163
Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy. 162
Subclinical functional and structural renal abnormalities predict new onset type 2 diabetes in patients with primary hypertension 162
Impact of target organ damage assessment in the evaluation of global risk in patients with essential hypertension. 160
INDIVIDUAZIONE DEL RUOLO DELLA GLUTAMINASI FOSFATO-DIPENDENTE E DELLA GLUTAMINASI FOSFATO-INDIPENDENTE NELLA PRODUZIONE RENALE DI AMMONIACA 159
AMINO ACID METABOLISM AND THE LIVER IN RENAL FAILURE 158
PROTEIN TURNOVER IN THE HUMAN KIDNEY 157
Amino acid imbalance in patients with chronic renal failure. 157
Renal metabolism of amino acids and ammonia in subjects with normal renal function and in patients with chronic renal insufficiency. 156
Nephrin expression is reduced in human diabetic nephropathy: Evidence for a distinct role for glycated albumin and angiotensin II 153
Mechanisms of renal ammonia production and protein turnover 153
Creatinine clearance and early signs of target organ damage in primary hypertension 152
136) CKD awareness and blood pressare control in the primari care hypertensive population 152
Inappropriate left ventricular mass is associated with microalbuminuria independently of left ventricular hypertrophy in primary hypertension 152
Renal and cardiac abnormalities in primary hypertension 152
Combined effect of albuminuria and estimated glomerular filtration rate on cardiovascular events and all-cause mortality in uncomplicated hypertensive patients 151
Microalbuminuria identifies overall cardiovascular risk in essential hypertension: an artificial neural network-based approach. 151
Sub-clinical organ damage in hypertension and obesity 151
Predicting cardiovascular risk using creatinine clearance and an artificial neural network in primary hypertension 150
Abnormalities in amino acid metabolism in patients with chronic renal failure. A pathophysiological approach to the nutritional treatment. I. Studies in the postabsorptive state 149
Combined use of urinary neutrophil gelatinase-associated lipocalin (uNGAL) and albumin as markers of early cardiac damage in primary hypertension. 149
Increased ambulatory arterial stiffness index is associated with target organ damage in primary hypertension 148
Arterial hypertension and microalbuminuria in IDDM: the Italian Microalbuminuria Study 148
Kidney protein dynamics and ammoniagenesis in humans with chronic metabolic acidosis 147
Coronary flow reserve is impaired in hypertensive patients with subclinical renal damage 147
EFFECTS OF CHRONIC RENAL INSUFFICIENCY AND METABOLIC ACIDOSIS ON GLUTAMINE METABOLISM IN MAN 146
Free and sulfoconjugated catecholamines in normotensive uremic patients: effects of hemodialysis. 145
Phenylalanine hydroxylation across the kidney in humans 145
Apoptosis in the kidneys of patients with type 2 diabetic nephropathy. 145
Mild renal dysfunction and renal vascular resistance in primary hypertension 145
Metabolic syndrome and ambulatory arterial stiffness index in non-diabetic patients with primary hypertension. 145
SPLANCHNIC AMINO ACID AND PROTEIN TURNOVER IN HUMANS: INSIGHT FROM ISOTOPE DILUTION AND CATHETERIZATION STUDIES 144
Evaluation of subclinical organ damage for risk assessment and treatment in the hypertensive patient: role of microalbuminuria. 144
Renal ammoniagenesis in an early stage of metabolic acidosis in man 143
Renal metabolism of amino acids in early insulin-dependent diabetes mellitus 143
METABOLIC SYNDROME AND CARDIOVASCULAR RISK IN PRIMARY HYPERTENSION. 143
Muscle protein synthesis and degradation in hemodialysis (HD) patients with protein-energy malnutrition (PEM) 142
Apoptosis induced by serum withdrawal in human mesangial cells. Role of IGFBP-3 140
Midwall fractional shortening identifies extracardiac organ damage in essential hypertension 140
DETERMINANTS OF THE PARTITION OF RENAL AMMONIA PRODUCTION BETWEEN URINE AND VENOUS BLOOD IN MAN WITH METABOLIC ACID-BASE DISTURBANCES 139
AMINO ACID BIOSYNTHESIS 138
Microalbuminuria and subclinical cerebrovascular damage in essential hypertension 138
[Activity of renal enzymes producing ammonia from glutamine in the absence of phosphate: 2. Effect of phosphate dependent glutaminase inhibition by heating]. 138
Renal metabolism of C peptide in type I (insulin-dependent) diabetic patients 138
EFFECTS OF HEMODIALYSIS ON GUANIDINO-PROPIONIC ACID METABOLISM 138
Genetic polymorphism of the renin-angiotensin system and organ damage in essential hypertension 137
Cardiovascular and renal risk assessment as a guide for treatment in primary hypertension. 137
Skeletal muscle protein synthesis and degradation in patients with chronic renal failure 137
Abnormalities in amino acid metabolism in patients with chronic renal failure. A pathophysiological approach to the nutritional treatment. II. Studies after amino acid ingestion 137
Renal ammoniagenesis during the adaptation to metabolic acidosis in man. 136
BRAIN METABOLISM OF AMINO ACIDS AND AMMONIA IN PATIENTS WITH CHRONIC RENAL INSUFFICIENCY 135
Mild renal dysfunction and cardiovascular risk in hypertensive patients. 135
Emerging therapeutic strategies in diabetic nephropathy 135
Disposal of exogenous amino acids by muscle in patients with chronic renal failure 135
LEG METABOLISM OF AMINO ACIDS AND AMMONIA IN PATIENTS WITH CHRONIC RENAL FAILURE 135
RENAL METABOLISM OF C-PEPTIDE IN MAN 134
[Acute effects of peritoneal dialysis on muscle protein turnover]. 133
Serum uric acid as a marker of target organ damage in primary hypertension 133
Renal ammoniagenesis in humans with chronic potassium depletion 131
Splanchnic exchange of amino acids after amino acid ingestion in patients with chronic renal insufficiency 131
Role of microalbuminuria in the assessment of cardiovascular risk in essential hypertension 131
MICROALBUMINURIA, CARDIOVASCULAR, AND RENAL RISK IN PRIMARY HYPERTENSION. 130
EFFETTI DELL'INSUFFICIENZA RENALE CRONICA SUL METABOLISMO DELLA TIROSINA E DELLA FENILALANINA. 130
EFFETTI DELLE VARIAZIONI DEL pH DEL BAGNO DI DIALISI SULL'EQUILIBRIO ACIDO-BASE (EAB) DEI PAZIENTI IN CORSO DI EMODIALISI 130
Acute effects of peritoneal dialysis with dialysates containing dextrose or dextrose and amino acids on muscle protein turnover in patients with chronic renal failure 130
AMINO ACID METABOLISM IN RENAL FAILURE 130
WHOLE BODY AND ORGAN PROTEIN TURNOVER IN CHRONIC RENAL FAILURE 129
Amino acid metabolism, substrate availability and the control of protein dynamics in the human kidney 129
Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective. 129
Abnormalities in blood amino acid profile after a protein meal in patients with chronic renal failure. Kidney Int Suppl. 1989 Nov;27:S212-5. 129
Taurine prevents apoptosis induced by high ambient glucose in human tubule renal cells 129
Global risk stratification in primary hypertension: the role of the kidney 129
EFFECT OF AMINO ACID INGESTION ON BLOOD AMINO ACID PROFILE IN PATIENTS WITH CHRONIC RENAL FAILURE 129
LEUCINE METABOLISM AND PROTEIN DYNAMICS IN THE HUMAN KIDNEY 128
TT virus infection in haemodialysis patients 128
Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure 127
Serum uric acid levels predict new onset type 2 diabetes in hospitalized patients with primary hypertension: the MAGIC study. 127
Ammonia and amino acid metabolism y the portal-vein-drained viscera in chronic renal insufficiency. 127
Acute effects of peritoneal dialysis with dialysates containing dextrose or dextrose and amino acids on muscle protein synthesis and degradation 127
Metabolic syndrome and microalbuminuria predict renal outcome in non-diabetic patients with primary hypertension: the MAGIC study. 126
Totale 15.053
Categoria #
all - tutte 78.791
article - articoli 69.201
book - libri 0
conference - conferenze 4.507
curatela - curatele 0
other - altro 708
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.375
Totale 157.582


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021108 0 0 0 0 0 0 0 0 0 0 0 108
2021/20222.592 56 213 142 322 126 187 192 589 69 215 152 329
2022/20232.571 240 115 30 265 421 489 3 238 462 14 248 46
2023/20241.058 66 165 19 108 80 151 43 88 75 9 100 154
2024/20253.055 45 254 86 185 501 322 245 402 142 159 348 366
2025/20265.063 609 109 242 438 688 613 962 253 313 483 271 82
Totale 26.388